Advanced Heart Failure & Transplant Cardiology

Better systems of care for the sickest heart failure patients.

Clinician-scientist, program director, and principal investigator — helping patients, hospitals, and industry heart failure outcomes through advanced clinical care, precision medicine, and FDA-regulated clinical trials.

ABIM — CARDIOVASCULAR DISEASE AND ADV. HF & TRANSPLANT CARDIOLOGYHFSA AWARD-WINNING PROGRAM 2025
AHA AWARD-WINNING PROGRAM 2026
Sharp Physician Leadership Academy
25+
Peer-Reviewed Publications
10+
Years Leading HF Programs
4
PI-Led Clinical Trials
3
Continents Lectured

About

Dr. Burhan Mohamedali

Portrait of Burhan Mohamedali, MD

Dr. Burhan Mohamedali is Director of the Congestive Heart Failure Program at Sharp Chula Vista Medical Center and Director of the CHF Program & Research at the Cardiovascular Institute of San Diego (CVISD), where he leads clinical care, program development, and research initiatives in advanced heart failure. He holds an affiliate faculty appointment at UC San Diego.

Prior to relocating to San Diego, Dr. Mohamedali led the heart transplant program at Rush University Medical Center in Chicago, gaining deep experience in advanced heart failure and transplantation within a major academic medical center. Since then, he has continued to lead heart failure and transplant programs across both academic and private practice settings, giving him a broad perspective on how CHF care can be delivered effectively across different institutional models. He maintains active industry collaborations spanning gene and cell therapy, precision medicine, and device-based therapeutics, keeping his practice at the forefront of emerging treatment modalities.

His particular area of focus is the design and implementation of heart failure programs and systems of care—building the infrastructure, protocols, and clinical pathways that allow hospital systems to deliver high-quality CHF management from the ground up. This work is especially oriented toward resource-limited environments, where he applies his experience to strengthen care delivery in settings that often face the greatest systemic challenges.

Dr. Mohamedali has published more than 25 peer-reviewed papers, contributed a book chapter on cardio-nephrology, and lectured internationally across the U.S., China, Tanzania, and India.

Experience

Leadership & Appointments

Cardiovascular Institute of San Diego (CVISD)

2017 – Present

Director, Congestive Heart Failure Program & Research

Expanded access to genomic biomarker-driven therapeutics and device-based clinical trials in a private practice setting.

Sharp Chula Vista Medical Center

2021 – Present

Director, Congestive Heart Failure Program

Clinical pathways, digital monitoring, and biomarker-driven care. HFSA Outstanding Heart Failure Team Award (2025); Sharp C.O.R.E. Award (2024).

University of California San Diego

2022 – Present

Affiliate Faculty

Collaborator in multi-center genomic and translational cardiovascular research.

Rush University Medical Center

2014 – 2017

Medical Director, Advanced Heart Failure & Transplant Program

Directed inpatient/outpatient HF and transplant programs, LVAD program, and integration of novel device and genomic therapies.

Focus

Areas of Expertise

  • Advanced Heart Failure & Transplant Cardiology
  • Developing hospital-based heart failure programs and clinical care infrastructure
  • Clinical Trial Design & FDA Oversight
  • Translational Research & Industry Collaboration
  • Device & Digital Health Innovation
  • LVAD & Mechanical Circulatory Support
  • Cardiogenic Shock Systems of Care
  • GDMT Optimization & Readmission Reduction
  • Value-Based Cardiovascular Care
  • Population Health & Underserved Care Models

Research

Clinical Trials & Publications

Principal investigator on multiple FDA-regulated device, cell therapy, and pharmacotherapy trials, with 25+ peer-reviewed publications in advanced heart failure, LVAD outcomes, and transplant cardiology.

Principal Investigator

  • FINALITY-HF, REDEFINE-HF, CONFIRMATION-HF (2025–ongoing)
  • FIRE1-HF Trial
  • OPTIMIZER Smart Post-Approval Study – Sharp CVISD
  • Dream HF Trial – Stem cell therapy in chronic HF
  • Paragon HF Trial – ARNI vs. valsartan in HFpEF

Sub-Investigator

  • Champion Trial – WATCHMAN vs. DOAC
  • Beat-HF Trial – Baroreflex activation therapy
  • Ixcell Trial – Stem cell therapy for ischemic DCM
  • COAPT Trial – MitraClip in functional MR

Selected Publications

  • Mohamedali B, Doukky R, et al. MAP/CVP ratio as marker for RV failure post-LVAD. J Card Fail. 2017.
  • Mohamedali B, Yost G, Bhat G. Diabetes mellitus and LVAD outcomes. Tex Heart Inst J. 2017.
  • Poulin MF, Deka A, Mohamedali B, Schaer GL. Stem cells in systolic heart failure. Cell Transplant. 2016.
  • Mohamedali B, Tatooles A, Bhat G. Biventricular CentriMags as bridge to decision. Perfusion. 2014.
  • Mohamedali B, Bhat G, Zelinger A. LV dysfunction in donors. J Am Coll Cardiol. 2012.

Plus 20+ additional peer-reviewed publications and a book chapter in Cardio-nephrology: Confluence of the Heart and Kidney in Clinical Practice.

Recognition

Awards & Professional Leadership

Awards & Honors

  • AHA Get With The Guidelines® – Heart Failure Bronze Achievement Award (2026) – Sharp Chula Vista Medical Center
  • HFSA Best USA Heart Failure Team Award (2025)
  • Sharp Physician Leadership Academy Graduate (2025)
  • Sharp Chula Vista C.O.R.E. Award (2024)
  • ISHLT Young Investigator Finalist
  • HFSA Early Career Leadership Award
  • AHA Clinical Research Award

Societies & Councils

  • FDA Network of Experts (2016–2019)
  • ACC Heart Failure Council (2015–2018)
  • ISHLT HF/Transplant Council (2014–Present)
  • HFSA Early Career Committee

Latest Recognition

AHA Get With The Guidelines® — Heart Failure

Bronze Achievement Award, 2026

The American Heart Association recognizes Sharp Chula Vista Medical Center for continued success in using the Get With The Guidelines® program to deliver evidence-based heart failure care.

American Heart Association Get With The Guidelines Heart Failure Bronze Award 2026 for Sharp Chula Vista Medical Center

Education & Training

  • Advanced Heart Failure & Transplant Fellowship — University of Illinois at Chicago
  • Cardiology Fellowship — University of Illinois at Chicago
  • Internal Medicine Residency — University of Illinois at Chicago
  • Medical Doctorate (MD) — University of Kentucky
  • BS, Biology — Northern Kentucky University

Featured Post

LinkedIn Announcement

Consulting

Heart Failure Program Consulting

Hospitals do not need another heart failure lecture. They need a practical, multidisciplinary system that reliably moves patients from hospitalization to stability — the same approach behind an HFSA-recognized program.

Program Design

Development of heart failure service lines, transitional clinics, ED pathways, LVAD programs, and multidisciplinary care models.

Quality Improvement

Strategies to improve GDMT adoption, reduce avoidable readmissions, and meet national quality standards — informed by an HFSA award-winning program.

Clinical Trials & Industry

PI experience across FDA-regulated device, cell therapy, and pharmacotherapy trials; advisory work in gene/cell therapy and precision cardiovascular medicine.

Education

Speaking & Education

Dr. Mohamedali is available for grand rounds, hospital leadership sessions, physician education, advisory boards, and conferences on heart failure care delivery, GDMT implementation, cardiogenic shock, LVAD/transplant, and value-based cardiovascular care.

Suggested Topics

  • • Building a High-Performing Heart Failure Program
  • • The First 30 Days After HF Discharge
  • • GDMT in the Real World
  • • LVAD & Advanced Therapies: Patient Selection to Outcomes
  • • Cardiovascular Genomics & Precision Medicine
  • • Heart Failure Care for Vulnerable Populations

Selected Invited Lectures

  • Taiwanese Society of Cardiology — Guest Speaker, HFrEF Guidelines
  • Jakaya Kikwete Cardiac Institute, Tanzania — CHF, LVADs, Cardiogenic Shock
  • Indian College of Cardiology, Patna — LVADs & Emerging HF Therapies
  • American Heart Association — Heart failure, cardiomyopathy, renal transplant

Languages: English, Swahili, Hindi (fluent); Spanish (conversational).

The future of heart failure care is not only better medication — it is better systems of care.

Contact

Get in touch

For clinical, consulting, speaking, research, or advisory inquiries:

burhan@BurhanMohamedali.com

San Diego, California